UBS Group Trims Celsius (NASDAQ:CELH) Target Price to $92.00

Celsius (NASDAQ:CELH) had its price objective decreased by UBS Group from $99.00 to $92.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group’s price target indicates a potential upside of 26.44% from the company’s current price.

A number of other research firms have also weighed in on CELH. Stifel Nicolaus lowered their target price on Celsius from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Jefferies Financial Group upped their price target on Celsius from $98.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, March 18th. Wedbush reaffirmed an “outperform” rating and set a $100.00 price target on shares of Celsius in a research report on Friday, May 3rd. Bank of America lowered Celsius from a “buy” rating to a “neutral” rating and set a $65.00 price target for the company. in a research report on Friday, January 19th. Finally, Maxim Group upped their price target on Celsius from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $84.95.

Celsius Stock Performance

Celsius stock traded down $4.19 during midday trading on Wednesday, hitting $72.76. 967,602 shares of the company’s stock were exchanged, compared to its average volume of 4,734,544. The stock has a 50-day moving average price of $81.23 and a two-hundred day moving average price of $65.89. Celsius has a 52-week low of $34.74 and a 52-week high of $99.62. The company has a market cap of $16.81 billion, a P/E ratio of 94.09, a PEG ratio of 2.22 and a beta of 1.93.

Celsius (NASDAQ:CELH) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.07. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The firm had revenue of $355.70 million during the quarter, compared to analysts’ expectations of $390.37 million. During the same period in the prior year, the business earned $0.13 EPS. The company’s revenue for the quarter was up 36.9% compared to the same quarter last year. As a group, sell-side analysts expect that Celsius will post 1.09 earnings per share for the current year.

Insider Buying and Selling

In related news, major shareholder William H. Milmoe sold 428,568 shares of the company’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $59.67, for a total value of $25,572,652.56. Following the sale, the insider now owns 25,464,453 shares in the company, valued at approximately $1,519,463,910.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, major shareholder William H. Milmoe sold 428,568 shares of the company’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $59.67, for a total value of $25,572,652.56. Following the sale, the insider now owns 25,464,453 shares in the company, valued at approximately $1,519,463,910.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jarrod Langhans sold 4,079 shares of the stock in a transaction on Friday, April 19th. The shares were sold at an average price of $69.42, for a total value of $283,164.18. Following the sale, the chief financial officer now owns 83,670 shares in the company, valued at $5,808,371.40. The disclosure for this sale can be found here. Insiders have sold 2,043,363 shares of company stock worth $131,361,140 in the last 90 days. Insiders own 2.20% of the company’s stock.

Institutional Trading of Celsius

Several institutional investors have recently added to or reduced their stakes in CELH. Cambridge Investment Research Advisors Inc. boosted its stake in Celsius by 89.1% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 16,386 shares of the company’s stock valued at $2,812,000 after purchasing an additional 7,723 shares during the last quarter. Raymond James Financial Services Advisors Inc. lifted its holdings in shares of Celsius by 8.0% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 53,237 shares of the company’s stock valued at $9,135,000 after buying an additional 3,921 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Celsius by 8.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 428,602 shares of the company’s stock valued at $73,548,000 after buying an additional 33,597 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Celsius by 48.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,100 shares of the company’s stock valued at $1,390,000 after buying an additional 2,643 shares during the period. Finally, Advisor Partners II LLC lifted its holdings in shares of Celsius by 4.9% during the 3rd quarter. Advisor Partners II LLC now owns 1,858 shares of the company’s stock valued at $319,000 after buying an additional 87 shares during the period. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.